Arthur Tzianabos – Biography
Last update: 10 days agoExecutive profile
Arthur was Director at Stoke Therapeutics, and Director at Akouos.
Arthur Tzianabos is currentlyVenture Partner at 5AM Ventures - View - 5AM Ventures org chart
Chairman of the Board at Stoke Therapeutics - View - Stoke Therapeutics org chart
Director at Q32 Bio - View - Q32 Bio org chart
Create your alert
to follow the career of Arthur Tzianabos.
Education
Arthur Tzianabos has a PhD in Microbiology from University of New Hampshire and a Post Doctoral Fellowship in Immunology from Harvard Medical School.
They have also studied at University of New Hampshire :
Find more alumni from University of New Hampshire
They have also studied at Harvard Medical School :
Find more alumni from Harvard Medical School
More about Arthur Tzianabos
Selected links
Do you need to know more about Arthur Tzianabos? More results.
Participate
Social media
- Arthur Tzianabos on Google News, X (Twitter), LinkedIn, YouTube
- View the pictures of Arthur Tzianabos
The colleagues of Arthur Tzianabos
Company Colleagues
- At 5AM Ventures, Arthur Tzianabos has 23 colleagues including Andrew Schwab (Co-Managing Partner), Kush Parmar (Co-Managing Partner)…
- At Stoke Therapeutics, Arthur Tzianabos has 40 colleagues including Ian Smith (CEO), Jennifer Burstein (Director)…
- At Q32 Bio, Arthur Tzianabos has 24 colleagues including Jodie Morrison (CEO), Diyong Xu (Director)…
Industry Colleagues
- In the Biotechnology industry, Arthur Tzianabos has 35,756 colleagues in 2,406 companies located in 42 countries. 16,877 executive movements have been recorded in the last 12 months. Learn more about Biotechnology.
Report an error
Update the org chart details of Arthur Tzianabos.
Get in Touch
Here are a few tips for establishing great contacts.
and ask for Arthur Tzianabos.
